NLRP3 and Alzheimer disease: Combined with our prior results on Aβ [21, 22] and its relationship with NLRP3 inflammasome we mentioned above, benign regulative effect on Aβ and its downstream NLRP3/Caspase-1 pathway can be seen as the important mechanism of MA against AD.